Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 19 ... against biofilms (p <0.0001). For P. aeruginosa biofilms, the addition of azithromycin or rifampin to otherwise effective antibiotic combinations was frequently associated ...
2009 NOV 23 ... 2009 business objectives." Recent Accomplishments and Events Prescriptions of AzaSite (azithromycin ophthalmic solution) 1%, InSite Vision's product for the treatment of bacterial ...
2009 OCT 19 ... in two commercial products for the treatment of bacterial eye infections, AzaSite® (azithromycin ophthalmic solution) 1% and Besivance™ (besifloxacin ophthalmic suspension) 0.6%. ...
2009 NOV 16 ... the third quarter of 2008, reflecting an increase of 26%. Revenue from AZASITE® (azithromycin ophthalmic solution) 1% totaled $9.0 million in the third quarter of 2009, an increase ...
2009 NOV 2 ... for cystic fibrosis, which are both in Phase 3 development and AzaSite® (azithromycin ophthalmic solution) 1% for blepharitis, which is in Phase 2 development. Inspire ...
2009 NOV 2 ... Japan report. "The effect of macrolide antibiotics [erythromycin (EM), azithromycin (AZM) and josamycin (JOM)] on HGFs proliferation were examined by MTT assay. HGFs were ...
2009 NOV 1 ... year had an adjusted OR for aplastic anemia of 8.7 (CI: 0.87-87.93) and those exposed to azithromycin had an adjusted OR of 11.02 (CI 1.14-108.02). The incidence of aplastic anemia in Latin ...
2009 NOV 23 ... delivery in more than 7 days. Among those selling macrolides (n = 133), 93.3% would sell azithromycin in quantities consistent with more than a single course of medication. Compared with ...
2009 NOV 16 ... identify potential biomarkers of their activity, we have investigated the influence of azithromycin and clarithromycin on the inflammatory cascade leading to neutrophil infiltration into ...
2009 NOV 2 ... as used with 30,000 patients in the national Institutes of Health trial of the drug Azithromycin in 2006 1.31. Price sensitivity curve for RFID 1.32. ...
2009 NOV 16 ... within 24 h (versus approximately 20, 30, and 160 for telithromycin, clarithromycin, and azithromycin, respectively). This intracellular accumulation was suppressed by incubation at a pH of ...
2009 OCT 12 ... are the antibiotics with the highest predicted clinical efficacy, whereas cefaclor, azithromycin, erythromycin and clarithromycin are those with the lowest predicted clinical efficacy. ...
2009 NOV 1 ... drug combinations. Synergism (FICI <or=0.5) was observed between 6-mercaptopurine and azithromycin (seven isolates), clarithromycin, rifampicin, rifabutin (four isolates each) and ...
2009 NOV 23 ... top three selling products, Ginkgo Mihuan Oral Liquid, Arpu Shuangxin Oral Liquid, and Azithromycin Dispersible Tablets, were collectively $7.1 million and represented approximately 53.1% ...
2009 NOV 9 ... produce macrolide antibiotics. This large and growing class of drugs in China includes Azithromycin, Clarithromycin and Roxithromycin, which treat a wide range of bacterial based ...
